Chemical Structure : SB 239063
CAS No.: 193551-21-2
Catalog No.: PC-42803Not For Human Use, Lab Use Only.
SB 239063 is a potent, selective, orally available p38 MAPK inhibitor with IC50 of 44 nM for both p38α and p38β.
Packing | Price | Stock | Quantity |
---|---|---|---|
1 mg (Free Sample) | $28 | In stock | |
5 mg | $98 | In stock | |
10 mg | $148 | In stock | |
25 mg | $258 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SB 239063 is a potent, selective, orally available p38 MAPK inhibitor with IC50 of 44 nM for both p38α and p38β.
SB 239063 shows no activity (>100 μM) against the γ- and δ-kinase isoforms, and a panel of protein kinase.
SB 239063 inhibits IL-1 and TNF-alpha production in LPS-stimulated human PBMCs (IC50= 0.12 and 0.35 uM).
SB 239063 reduces inflammatory cytokine production, airways eosinophil infiltration and persistence in vivo.
M.Wt | 368.4048 | |
Formula | C20H21FN4O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Cyclohexanol, 4-[4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]-, trans- |
1. Underwood DC, et al. J Pharmacol Exp Ther. 2000 Apr;293(1):281-8.
2. Underwood DC, et al. Am J Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L895-902.
3. Barone FC, et al. J Pharmacol Exp Ther. 2001 Feb;296(2):312-21.
4. Legos JJ, et al. Brain Res. 2001 Feb 16;892(1):70-7.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright